格隆汇2月2日丨洁特生物(688026.SH)公布，截至2026年1月31日，公司通过上海证券交易所系统以集中 竞价交易方式已回购公司股份272,799股，占目前公司总股本的比例为0.19%，回购成交的最高价为 18.43元/股，最低价为18.05元/股，支付的资金总额为497.14万元（不含交易佣金等费用）。 ...

| 证券代码：688026 | 证券简称：洁特生物 | 公告编号：2026-008 | | --- | --- | --- | | 转债代码：118010 | 转债简称：洁特转债 | | 二、回购股份的进展情况 根据《上市公司股份回购规则》及《上海证券交易所上市公司自律监管指引 第 7 号——回购股份》等相关规定，现将公司截至上月末回购股份的进展情况公 告如下： 截至 2026 年 1 月 31 日，公司通过上海证券交易所系统以集中竞价交易方式 已回购公司股份 272,799 股，占目前公司总股本 140,364,345 股的比例为 0.19%， 回购成交的最高价为 18.43 元/股，最低价为 18.05 元/股，支付的资金总额为 497.14 万元（不含交易佣金等费用）。 广州洁特生物过滤股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/12/31 | | | | | | --- | --- | --- | -- ...

Group 1 - The company has approved a share repurchase plan using its own funds, with a total amount between RMB 15 million and RMB 30 million, and a maximum repurchase price of RMB 25.32 per share [2] - The repurchase period is set for up to 12 months from the date of board approval [2] - The first repurchase occurred on January 28, 2026, with 272,799 shares bought back, representing 0.19% of the total share capital, at a price range of RMB 18.05 to RMB 18.43 per share, totaling RMB 4.9714 million [3] Group 2 - The company will adhere to relevant regulations and guidelines during the repurchase process and will disclose information regarding the progress of the share repurchase [5] - The repurchase is intended for future employee stock ownership plans or equity incentives [2]

Group 1 - The company, JieTe Bio, announced the repurchase of 272,799 shares on January 28, 2026, through the Shanghai Stock Exchange, representing 0.19% of the total share capital [2]

Group 1 - The company, Jiet Bio, announced its first share repurchase on January 28, 2026, buying back approximately 270,000 shares, which represents 0.19% of its total share capital of about 140 million shares [1] - The highest price for the repurchased shares was 18.43 yuan per share, while the lowest price was 18.05 yuan per share, with a total expenditure of 4.9714 million yuan [1] Group 2 - The industry is witnessing a significant shift towards semi-solid battery technology, with expectations for multiple new vehicle models to adopt this technology in the current year [1] - Major manufacturers are preparing for advancements in power battery technology, indicating a year of iteration and innovation in the sector [1]

广州洁特生物过滤股份有限公司（以下简称"公司"）于 2025 年 12 月 29 日召 开第四届董事会第二十六次会议，审议通过了《关于以集中竞价交易方式回购公 司股份的议案》，同意公司使用自有资金以集中竞价交易方式回购公司股份。本 次回购的股份将在未来适宜时机用于员工持股计划或股权激励。回购资金总金额 不低于人民币 1,500 万元（含）且不超过人民币 3,000 万元（含），回购股份价格 不超过人民币 25.32 元/股（含），回购股份期限为自公司董事会审议通过回购方 案之日起不超过 12 个月。 具体内容详见公司 2025 年 12 月 31 日披露于上海证券交易所（www.sse.com.cn） 的《关于以集中竞价交易方式回购股份方案的公告暨回购报告书》（公告编号： 2025-072）。 二、回购股份的进展情况 根据《上市公司股份回购规则》及《上海证券交易所上市公司自律监管指引 第 7 号——回购股份》等相关规定，现将公司首次回购股份情况公告如下： | 证券代码：688026 | 证券简称：洁特生物 | 公告编号：2026-007 | | --- | --- | --- | | 转债代码：118010 ...

Group 1 - The company, JieTe Bio (688026.SH), announced its first share buyback on January 28, 2026, through the Shanghai Stock Exchange [1] - A total of 272,799 shares were repurchased, representing 0.19% of the company's total share capital [1] - The buyback was executed at a maximum price of 18.43 yuan per share and a minimum price of 18.05 yuan per share, with a total expenditure of 4.9714 million yuan (excluding transaction commissions) [1]

Core Viewpoint - The company announced a share buyback plan aimed at employee stock ownership and equity incentives, with a budget of 15 million to 30 million yuan, and a maximum price of 25.32 yuan per share, valid until December 29, 2026 [1] Group 1 - The board meeting to approve the share buyback plan is scheduled for December 29, 2025 [1] - The first share repurchase occurred on January 28, 2026, with 272,800 shares bought back, representing 0.19% of the total share capital [1] - The transaction price for the initial buyback ranged from 18.05 to 18.43 yuan per share, with a total expenditure of 4.9714 million yuan [1]

Core Viewpoint - The company held its 27th meeting of the fourth board of directors on January 19, 2026, where two key resolutions were passed: the appointment of a new board secretary and the temporary use of idle raised funds to supplement working capital [1][5][18]. Group 1: Appointment of Board Secretary - The board approved the appointment of Mr. Bao Minzhang as the board secretary, effective from the date of the meeting until the current board's term ends [1][18]. - Mr. Bao has the necessary qualifications and experience, having completed the required training and possessing a strong professional background [18][19]. - The decision was made unanimously with 7 votes in favor and no opposition [3]. Group 2: Use of Idle Raised Funds - The board agreed to use up to RMB 200 million (20,000万元) of idle raised funds to temporarily supplement working capital for business-related activities [5][12]. - The funds will be used for a maximum period of 12 months and can be rolled over as needed, ensuring that the original investment projects are not affected [12][13]. - The decision was also unanimously approved with 7 votes in favor [6].

Core Viewpoint - Jiet Bio announced the approval of a proposal to temporarily use part of its idle raised funds to supplement working capital, amounting to no more than RMB 200 million [1] Group 1: Company Actions - The company held its 27th meeting of the fourth board of directors on January 19, 2026, where the proposal was reviewed and approved [1] - The approved funds will be used for production and operational activities related to the company's main business [1] - The usage period for the funds is set to be no more than 12 months from the date of board approval, with the possibility of rolling use within this limit [1]